ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Data Quality And How It Impacts Clinical Trials

  Explore a shared platform that helps organizations overcome technical burdens, reduce expenditures, and accelerate the delivery of innovative therapies.

• The Future Of Remote Patient Monitoring In Decentralized Clinical Trials

  Remote Patient Monitoring (RPM) is not just an innovation—it's a catalyst redefining how clinical research is conducted in the digital age.

• Building A Gold Standard Trial Experience In Japan

  Hear how Medable worked with a Japanese sponsor to elevate their trial experience, achieve >90% patient and site adherence, and beat their forecasted FPI date, creating new eCOA standards adopted across all the customer’s vendors.

• 5 Trends To Watch This Year

  Explore 2026 policy trends across drug‑pricing actions, affordability pressures, value‑driven evaluation, shifts in global innovation, and new AI regulatory applications.

• A Better Approach To eConsent: Flexibility With Enabled Technology

  Electronic consent, or eConsent, digitalizes the trial participant consent process through increasingly simplified, interactive, educational models designed to improve comprehension and boost engagement.

• Essity Uses eConsent To Optimize Enrollment

  See how a global hygiene and health company was able to deploy virtual methods through a strategic partnership to recruit and retain participants, streamline consent, and analyze patient data.

• How We Used Intelligent Automation to Transform Vendor Selection

  Discover how your small biotech can achieve faster timelines, improved cost control, and more strategic, transparent choices with a platform leveraging intelligent automation.

• Televisits In Clinical Trials: Why Integrate A Telemedicine Feature In Your eCOA Trials?

  If remote visits are planned in both decentralized and hybrid trials, how precisely do the televisits work and how beneficial can this really be to study patients, site staff, and sponsors?

• eClinical Platform Accelerates COVID-19 Treatment Trial By 2 Weeks

  Examine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.

• Managing Drug And Data Requirements In Decentralized Clinical Trials

  Running a global decentralized clinical trial requires a deep understanding of the differences in FDA and EMA requirements for investigational products and patient data.